ACLARIS THERAPEUTICS INC shareholders Q3 2023

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CREDIT SUISSE AG/ 99,107$678,8830.00%
STATE OF WISCONSIN INVESTMENT BOARD 44,627$305,6950.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 463,234$3,173,1530.00%
MORGAN STANLEY 1,698,391$11,633,9790.00%
AMALGAMATED BANK 10,484$720.00%
BlackRock Inc. 5,607,890$38,414,0460.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 20,317$139,1710.00%
Walleye Trading LLC 32,724$224,1590.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 417,000$2,856,4500.00%
Truvestments Capital LLC 150$1,0280.00%
Lindbrook Capital, LLC 284$1,9450.00%
PRICE T ROWE ASSOCIATES INC /MD/ 129,887$8900.00%
Invesco Ltd. 39,718$272,0690.00%
Allworth Financial LP 38$2610.00%
JANUS HENDERSON GROUP PLC 20,353$139,6180.00%
ProShare Advisors LLC 13,659$93,5650.00%
MILLENNIUM MANAGEMENT LLC 100,000$685,0000.00%
D. E. Shaw & Co., Inc. 66,010$452,1690.00%
ROYAL BANK OF CANADA 13,305$92,0000.00%
MILLENNIUM MANAGEMENT LLC 57,400$393,1900.00%
External links

This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.